Opening by Chairman, Inaugural Address, Keynote Address, Special Address
Join global MEDTech CEOs for a conversation on why India is fast emerging as the next growth frontier. Explore what makes the Indian market unique, the evolving policy and innovation landscape, and how global leaders are positioning to unlock its full potential.
This session will discuss how India can become a competitive global hub for medical devices. We will explore strategies around innovation, regulatory compliance, talent development, infrastructure, and global market access to unlock the country’s full MEDTech potential.
MEDTech Unplugged offers bold perspectives and unfiltered insights from the industry's most influential voices. In these candid conversations, MEDTech’s top leaders unpack the future of healthcare innovation—navigating complexity, championing change, and shaping what’s next for the sector.
This session will explore the need for a multi-level innovation approach for the Indian Medical Device sector, simultaneously focusing on incremental improvements, substantial enhancements, and breakthrough technologies, while strengthening regulatory alignment, talent pipelines, infrastructure, and intellectual property frameworks.
The session will address the important question: "How can India bridge the gap between innovative medical devices and expanded access to healthcare technologies, ensuring that global breakthroughs are available to every citizen?” and define actionable pathways for ensuring that MEDTech innovation translates into real-world healthcare access across India.
This session explores how Indian MEDTech firms are leveraging private equity and public markets to scale, localize manufacturing, and expand globally, with experts discussing the capital and policy levers driving India’s rise as a global MEDTech hub. It will highlight how strategic investments, incentives like PLIs, and global partnerships are accelerating the sector’s transformation.
Opening by APACMed CEO, Inaugural Address, Keynote Address, Special Address
This session will unpack the promise, pitfalls and path forward for AI in MEDTech with perspectives from government, industry, hospital and regulators. Speakers will explore key themes of AI tools deployment across MEDTech, the vision of a unified data source, governing AI’s usage in healthcare and upskilling the healthcare workforce to work with AI.
This session will explore how regulatory agility is becoming a critical enabler of innovation in the MEDTech sector. As technologies like AI, digital health, and personalized medicine rapidly evolve, traditional regulatory pathways must adapt to ensure timely patient access without compromising safety. This session will feature leading regulators and industry experts as they share real-world examples of how regulatory frameworks are evolving to keep pace with disruption.
As India deepens strategic ties with the U.S. and EU through new trade, innovation, and regulatory frameworks, what will this mean for the future of MEDTech? This session brings together policymakers, industry leaders, and global experts to unpack how initiatives like TRUST, INDUS, and the upcoming Bilateral Trade Agreements could position India as a MEDTech manufacturing and innovation hub. Explore the risks, opportunities, and strategic pathways for global collaboration in a fast-evolving landscape.
As India targets Universal Health Coverage by 2030, its expanding medical device market plays a critical role in advancing equitable healthcare. This session will explore how reimbursement reforms can drive sustainable market growth and improve patient access to innovative technologies across the country.
This session will explore strategies to expand access to advanced diagnostics in Tier 2 and 3 regions by strengthening the ecosystem—enabling regulatory environment, improving IT infrastructure, workforce capabilities, and supply chain efficiencies. Discussions will focus on bridging gaps through healthcare decentralization from manufacturing to last-mile delivery to enable timely and equitable diagnosis.
Innovation in MEDTech has transformative potential to advance the delivery of healthcare. It also raises significant legal and ethical considerations given the pace of change. This session will explore the key themes of regulatory compliance, data privacy and protection, cybersecurity, and the criticality of training and education in enabling effective adoption of new technologies and their associated risks.

JOHN COLLINGS
APACMed Chairman & President, Asia Pacific, Stryker

SH. JP NADDA
Hon’ble Union Minister of Health and Family Welfare, Govt of India*

DR SANGITA REDDY
Joint Managing Director, Apollo Hospitals

DR VINOD K PAUL
Member, Health, Niti Aayog, Govt of India

KEVIN LOBO
CEO & Chairman, Stryker

Tim Schmidt
Executive Vice President, Worldwide Chairman, Medtech, J&J

SHEREEN BHAN
Managing Editor of CNBC-TV18

SH.AMIT AGRAWAL
Secretary, Dept. of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt of India

DR. RAJIV BAHL
Secretary, Department of Health Research & Director General, ICMR, Govt of India

SMT PUNYA SALILA SRIVASTAVA
Secretary, Ministry of Health and Family Welfare, Govt of India

SH B.V.R. SUBRAHMANYAM
CEO NITI Aayog*

MASSIMILIANO COLELLA
Chief Executive Officer - Chairman & Board Director, CMR Surgical

KATARZYNA MAZUR-HOFSÄß
CEO of Care Enablement and Member, Management Board, Fresenius Medical Care

MAJID KADDOUMI
Senior Vice President & President, Europe, Middle East, Africa & APAC (EurAsia), Medtronic

OZLEM FIDANCI
Head of International Market, Phillips
DIALOGUE DEN - I | DIALOGUE DEN - I | DIALOGUE DEN - I | |
---|---|---|---|
10:00 AM - 11:00 AM |
FUNDING INNOVATION, ENABLING CARE:
A Payor–MedTech Dialogue ![]() |
CTRL + HEAL:
How AI is Rebooting MedTech ![]() |
INDIA NEXT:
The Smart Investment Destination for MedTech ![]() |
|
|||
12:00 PM - 13:30 PM |
INDIA RISING :
MedTech in a New Global Order ![]() |
AGILE REGULATION:
Accelerated Access ![]() |
|
|
|||
14:30 PM - 16:00 PM |
FROM LABS TO LIVES:
Expanding Diagnostic Equity Across India ![]() |
COMPLIANCE WHIPLASH:
What’s Next for Indian MedTech? ![]() |
|
|